Altered lymphocyte antigen expressions in HIV infection: a study by quantitative flow cytometry.
To identify surface antigen changes that may contribute to the immune deficiency in infection with the human immunodeficiency virus (HIV), we quantified, by double-staining flow cytometry, the number of antigens of the main peripheral blood lymphocyte subsets from 30 HIV-positive persons and compared them with those of 19 HIV-negative healthy donors. Standard microbeads with different capacities to bind mouse immunoglobulins were used to convert the mean fluorescence intensity values into numbers of antigen molecules per cell, measured as antibody binding capacity. The level of expression of different lymphocyte antigens in HIV-infected patients differs from that seen in normal blood lymphocytes. Some of these surface markers are decreased, whereas others are increased, and their expression is modulated depending on the specific cell subset considered. The expression of CD3, CD4, and CD8 on T lymphocytes is significantly decreased; moreover, CD3 is down-regulated on activated and nonactivated T lymphocytes and on CD4 and CD8 cells. In contrast, the expression of CD2 on T cells is significantly increased. Natural killer cells exhibit down-regulation of CD7, normal levels of CD8 and CD56, and overexpression of CD2. Our results also identified, for most of these antigens, quantitative differences in membrane expression according to different disease stages, as assessed by the CD4 T-cell count. Quantitative flow cytometry therefore may provide useful insights into the lymphocyte functional defects characterizing HIV infection.
Ginaldi
L
L
Department of Internal Medicine, L'Aquila University, Italy.
De Martinis
M
M
D'Ostilio
A
A
Di Gennaro
A
A
Marini
L
L
Quaglino
D
D
D000328:Adult; D000818:Animals; D019011:Antigens, CD7 / Q000032:analysis / Q000235:genetics; D000954:Antigens, Surface / Q000032:analysis*; D018801:CD2 Antigens / Q000032:analysis / Q000235:genetics; D017252:CD3 Complex / Q000032:analysis* / Q000235:genetics; D015704:CD4 Antigens / Q000032:analysis* / Q000235:genetics; D019002:CD56 Antigen / Q000032:analysis / Q000235:genetics; D016827:CD8 Antigens / Q000032:analysis* / Q000235:genetics; D018450:Disease Progression; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D005455:Fluorescent Antibody Technique; D015658:HIV Infections / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology / Q000473:pathology; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D051379:Mice; D010641:Phenotype
D019011:Antigens, CD7; D000954:Antigens, Surface; D018801:CD2 Antigens; D017252:CD3 Complex; D015704:CD4 Antigens; D019002:CD56 Antigen; D016827:CD8 Antigens